Skip to content

Cohorts for patients with acute leukemia

Cohort for biomarkers to predict prognosis and treatment response in acute leukemia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007129
Enrollment
2250
Registered
2022-03-29
Start date
2022-03-14
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1st step [retrospective cohorts] ? adult (at least 19 years) acute leukemia patients ? acute leukmia according to WHO classification (WHO 2016) ? patients with available medical records 2nd step (patients) [prospective cohorts] ? adult (at least 19 years) acute leukemia patients ? newly diagnosed acute leukmia according to WHO classification (WHO 2016) ? who willing to participate in this prospective cohort study and to agree to provide additional PB and/or BM sample during the routine diagnostic or treatment procedure 2nd step (healthy donors) [prospective cohorts] ? family donors who will donate their PB or BM to their family patients ? who willing to participate in this prospective cohort study and to agree to provide additional PB and/or BM sample during the routine treatment procedure

Exclusion criteria

Exclusion criteria: 1st step [retrospective cohorts] ? patients with no available medical records 2nd step [prospective cohorts] ? patients: who do not want to participate in this clinical trial and do not want to provide additional PB and/or BM sample ? healthy donors: who do not want to participate in this clinical trial and do not want to provide additional PB and/or BM sample

Design outcomes

Primary

MeasureTime frame
Clinical outcomes (remission, relapse, survival, complications after chemotherapy and/or transplantation) and relevant characteristics (patients' character, disease character, biomarker)

Secondary

MeasureTime frame
biomarkers for prediction of clinical outcomes

Countries

Korea, Republic of

Contacts

Public ContactSilvia Park

The Catholic University of Korea

silvia.park@catholic.ac.kr+82-2-2258-6755

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026